Bellerophon Therapeutics, Inc.
BLPH · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $8,596 | $29,459 | $52,007 | $23,643 |
| - Cash | $6,924 | $24,736 | $47,557 | $9,874 |
| + Debt | $203 | $955 | $1,660 | $2,317 |
| Enterprise Value | $1,875 | $5,678 | $6,110 | $16,086 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$65 | -$102 | -$147 | -$348 |
| % Margin | – | – | – | – |
| EBITDA | -$22,183 | -$19,454 | -$26,706 | -$14,720 |
| % Margin | – | – | – | – |
| Net Income | -$19,831 | -$17,756 | -$24,728 | -$13,267 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.08 | -1.87 | -3.17 | -2.95 |
| % Growth | -11.2% | 41% | -7.5% | – |
| Operating Cash Flow | -$17,770 | -$22,821 | -$19,884 | -$12,936 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$17,770 | -$22,821 | -$19,884 | -$12,936 |